2000
Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania
Fawzi W, Mbise R, Spiegelman D, Fataki M, Hertzmark E, Ndossi G. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. The Journal Of Pediatrics 2000, 137: 660-667. PMID: 11060532, DOI: 10.1067/mpd.2000.110136.Peer-Reviewed Original ResearchConceptsRespiratory tract infectionsHuman immunodeficiency virusTract infectionsVitamin APlacebo-controlled trialAcute respiratory infectionsSevere watery diarrheaRisk of diarrheaEffect of vitaminDuration of episodesRapid respiratory rateLow-cost interventionAcute diarrheaRespiratory infectionsImmunodeficiency virusWatery diarrheaAdverse outcomesUndernourished childrenHigh riskDiarrheaRespiratory rateInfectionSmall riskPlaceboDar es Salaam
1999
Effects of Long‐Acting Versus Short‐Acting Calcium Channel Blockers Among Older Survivors of Acute Myocardial Infarction
Gillman M, Ross‐Degnan D, McLaughlin T, Gao X, Spiegelman D, Hertzmark E, Goldman L, Soumerai S. Effects of Long‐Acting Versus Short‐Acting Calcium Channel Blockers Among Older Survivors of Acute Myocardial Infarction. Journal Of The American Geriatrics Society 1999, 47: 512-517. PMID: 10323641, DOI: 10.1111/j.1532-5415.1999.tb02562.x.Peer-Reviewed Original ResearchConceptsCalcium channel blockersAcute myocardial infarctionShort-acting calcium channel blockersCardiac rehospitalizationMyocardial infarctionChannel blockersRelative riskOlder survivorsActing calcium channel blockerSeparate Cox regression modelsDihydropyridine calcium channel blockerRetrospective cohort studyCoronary heart diseaseDrug claims dataCox regression modelDrug benefit programCause mortalityClinical characteristicsCohort studyEligible subjectsRehospitalization ratesAdverse outcomesHeart diseaseOutcome measuresRehospitalization
1997
Adverse Outcomes of Underuse of β-Blockers in Elderly Patients-Reply
Soumerai S, McLaughlin T, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse Outcomes of Underuse of β-Blockers in Elderly Patients-Reply. JAMA 1997, 277: 1436-1437. DOI: 10.1001/jama.1997.03540420032022.Peer-Reviewed Original ResearchCalcium channel blockersChannel blockersΒ-blockersNondihydropyridine calcium channel blockersNational evidence-based guidelinesDihydropyridine calcium channel blockerΒ-blocker useAdministrative claims databaseLipid-lowering agentsEvidence-based guidelinesEffective drug classClaims databaseAdverse outcomesDrug classesComparative efficacyBlockersCommunity settingsPatients' repliesAspirinPrevious reportsUnderuseOutcomesPatientsTrialsAdverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997, 277: 115-21. PMID: 8990335, DOI: 10.1001/jama.277.2.115.Peer-Reviewed Original ResearchConceptsCalcium channel blockersCalcium channel blocker useAdverse outcomesChannel blockersBlocker useEligible patientsMyocardial infarctionRelative riskMortality rateAcute myocardial infarction survivorsBaseline risk variablesCardiac hospital readmissionsElderly AMI survivorsBeta-blocker therapyBeta-blocker usePredictors of survivalRisk of deathRetrospective cohort designAcute myocardial infarctionDemonstrable adverse effectsMyocardial infarction survivorsPrescription drug coverageMeasurable adverse outcomesBeta blockersElderly patientsAdverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction
Soumerai S, McLaughlin T, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction. JAMA 1997, 277: 115-121. DOI: 10.1001/jama.1997.03540260029031.Peer-Reviewed Original ResearchCalcium channel blockersCalcium channel blocker useΒ-blockersAdverse outcomesChannel blockersBlocker useEligible patientsMyocardial infarctionRelative riskMortality rateAcute myocardial infarction survivorsBaseline risk variablesCardiac hospital readmissionsElderly AMI survivorsΒ-blocker therapyΒ-blocker usePredictors of survivalRisk of deathRetrospective cohort designAcute myocardial infarctionDemonstrable adverse effectsMyocardial infarction survivorsNew β-blockerPrescription drug coverageMeasurable adverse outcomes